Netherlands· NL-296d313000f0

Levemir Flexpen 100 eenheden/ml oplossing voor injectie in een voorgevulde pen

A insulin detemir product containing insuline detemir, registered in Netherlands by Novo Nordisk A.S.. The same ATC class is registered in 14 of our 19 countries.

ATC A10AE05

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about insuline detemirAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Insulin detemir is registered in 14 of 19 countries.

Countries holding a registration under ATC A10AE05 (insulin detemir), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
9 of them publish a price we can compare per daily dose

Search insulin detemir products by name

Insulin detemir · ATC A10AE05

14 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)

Active substance: INSULINE DETEMIR
Manufacturer: Novo Nordisk A.S.
Country: Netherlands (NL)
ATC code: A10AE05
ATC class: Insulin detemir
Defined daily dose: 40 E, P
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
EU/1/04/0278

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

434 interactions on record for insulin detemir.

Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check insulin detemir against other medicines How interaction checks work

Insulin detemir · interactions on record

434 records

15 severe
368 moderate
50 minor

Most severe, free to view

SucralfateA02BX02moderate
ThiethylperazinA04AB03moderate
TriflupromazinA04AD06moderate
PrednisoloneA07EA01moderate

1 more interaction with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Insulin detemir in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All insulin detemir products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

Iceland · Levemir Flexpen, Levemir Flextouch
Norway · Levemir Flexpen, Levemir Flextouch

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/7f3058ba-a611-4704-92c3-512cc96d6574
GET /v1/drugs/7f3058ba-a611-4704-92c3-512cc96d6574?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": "Subcutaan gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/levemir-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Insulin Detemir",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp71818",
  "excipients": [
    "DINATRIUMWATERSTOFFOSFAAT 2-WATER (E 339)",
    "FENOL",
    "GLYCEROL (E 422)",
    "METACRESOL",
    "NATRIUMCHLORIDE",
    "NATRIUMHYDROXIDE (E 524)",
    "WATER VOOR INJECTIE",
    "ZINKDIACETAAT 2-WATER (E 650)",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "INSULINE DETEMIR"
  ],
  "leaflet_url": null,
  "authorised_at": "2004/06/01",
  "procedure_number": "EMEA/H/C/000528",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/04/0278",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about insulin detemir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console